GSK's New Vaccine Kept Emma Walmsley in Her Job and an Activist at Bay

A scientists working in a laboratory, dedicated to cell culture and protein expression for biopharmaceutical and drug evaluation, at the GSK Plc R&D hub in Stevenage, UK, on Wednesday, April 17, 2024. At the research hub, scientists have embraced AI, machine-learning and functional genomics to try to improve the success rates of clinical trials. Photographer: Vivian Wan/Bloomberg via Getty Images
A scientists working in a laboratory, dedicated to cell culture and protein expression for biopharmaceutical and drug evaluation, at the GSK Plc R&D hub in Stevenage, UK, on Wednesday, April 17, 2024. At the research hub, scientists have embraced AI, machine-learning and functional genomics to try to improve the success rates of clinical trials. Photographer: Vivian Wan/Bloomberg via Getty Images
GSK's New Vaccine Kept Emma Walmsley in Her Job  and an Activist at Bay
PURCHASE A LICENCE
How can I use this image?
£375.00
GBP

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
2153417489
Collection:
Bloomberg
Date created:
17 April, 2024
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
UK GSK
Max file size:
3881 x 2588 px (32.86 x 21.91 cm) - 300 dpi - 4 MB